+91-33-4600-9199  (India), +1-414-240-5010 (U.S.)
Gadolinium-based Contrast Media Market is expected to witness 4.0% CAGR between 2020-2030- Market Insights, analysis, trends, and forecast - Sheer Analytics and Insights.
Published : February 2021

According to a new market research report published by sheer analytics and insights, “The Gadolinium-based Contrast Media Market was $456.32 Mn in 2020, and it is highly expected to reach $678.40 Mn by 2030. It is eventually growing at a commendable high compound of annual growth rate CAGR of 4.0% between 2020-2030”. It is eventually growing at a commendable high compound of annual growth rate CAGR of 4.0% between 2020-2030, as per the latest market research report titled Gadolinium-based Contrast Media Market - Global industry analysis, size, share, growth, trends and forecast, 2020 – 2030.

The growth of this market is mainly because of the advancements in technologies and long-term chronic diseases. The growing prevalence of the complex morbidities and label expansion like acquisitions and mergers by the key players. Around six out of ten people in the U.S. do suffer from chronic disease and four out of ten people suffer from comorbidity. It is a chronic disease that leads to death and disability in the country. So these are the main factors that will help to accelerate the growth of this market.

Geographically, The Gadolinium-based Contrast Media Market is divided into global regions like North America, Europe, Asia- Pacific, Latin America, Middle East, and Africa.   

Major Players In Gadolinium-based Contrast Media Market

Some of the major players in the Gadolinium-based Contrast Media Market include Bayer AG, GE Healthcare, Guerbet, Lantheus Medical Imaging, Inc., Bracco Diagnostic, Inc., and Trivitron Healthcare.

The Gadolinium-based Contrast Media Market Has Been Segmented Into:

Gadolinium-based Contrast Media Market, By Type

  • Extracellular Agents
  • Blood Pool Agents
  • Hepatobiliary Agents

Gadolinium-based Contrast Media MarketBy Modality

  • MRI
  • MRA

Gadolinium-based Contrast Media MarketBy Indication

  • Cardiovascular
  • Neurology
  • Cancer
  • Other (Musculoskeletal)

Gadolinium-based Contrast Media MarketBy Region

  • North America
    • USA
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, Middle East & Africa
    • Brazil
    • South Africa
    • UAE
    • Rest of LAMEA
Registered Office
RDB Boulevard, 8th Floor, Plot K 1, Sector 5, Block EP and GP, Kolkata 700091, India.
Contact Us
Stay Informed
Submit Your Query
Hot Links